RESUMEN
In equine and racing practice, detomidine and butorphanol are commonly used in combination for their sedative properties. The aim of the study was to produce detection times to better inform European veterinary surgeons, so that both drugs can be used appropriately under regulatory rules. Three independent groups of 7, 8 and 6 horses, respectively, were given either a single intravenous administration of butorphanol (100 µg/kg), a single intravenous administration of detomidine (10 µg/kg) or a combination of both at 25 (butorphanol) and 10 (detomidine) µg/kg. Plasma and urine concentrations of butorphanol, detomidine and 3-hydroxydetomidine at predetermined time points were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The intravenous pharmacokinetics of butorphanol dosed individually compared with co-administration with detomidine had approximately a twofold larger clearance (646 ± 137 vs. 380 ± 86 ml hr-1 kg-1 ) but similar terminal half-life (5.21 ± 1.56 vs. 5.43 ± 0.44 hr). Pseudo-steady-state urine to plasma butorphanol concentration ratios were 730 and 560, respectively. The intravenous pharmacokinetics of detomidine dosed as a single administration compared with co-administration with butorphanol had similar clearance (3,278 ± 1,412 vs. 2,519 ± 630 ml hr-1 kg-1 ) but a slightly shorter terminal half-life (0.57 ± 0.06 vs. 0.70 ± 0.11 hr). Pseudo-steady-state urine to plasma detomidine concentration ratios are 4 and 8, respectively. The 3-hydroxy metabolite of detomidine was detected for at least 35 hr in urine from both the single and co-administrations. Detection times of 72 and 48 hr are recommended for the control of butorphanol and detomidine, respectively, in horseracing and equestrian competitions.
Asunto(s)
Analgésicos/farmacocinética , Butorfanol/farmacocinética , Caballos/sangre , Imidazoles/farmacocinética , Condicionamiento Físico Animal , Analgésicos/administración & dosificación , Animales , Butorfanol/administración & dosificación , Butorfanol/sangre , Butorfanol/orina , Quimioterapia Combinada , Caballos/orina , Imidazoles/administración & dosificación , Imidazoles/sangre , Imidazoles/orina , Inyecciones IntravenosasRESUMEN
OBJECTIVE: To discover what influences women in the decision to deliver via vaginal birth after cesarean (VBAC). DESIGN: Descriptive and qualitative, influenced by principles of phenomenology and using content analysis to describe the lived experiences of women who choose VBAC. SETTING: Women were recruited from a postpartum unit in a hospital in the rural southeastern United States. PARTICIPANTS: Five women who had delivered via VBAC within 2 to 4 months before the study. RESULTS: The major influences that affect a woman's decision to choose VBAC are described. The dominant themes found were the woman's sense of control in the decision-making process; physician encouragement for VBAC; and delivery type outcome advantages, incorporating physical and emotional factors. CONCLUSION: Women are influenced by internal and external factors in their decision to choose VBAC. Their choices come from their personal experiences and should be encouraged by health care providers during all aspects of the childbearing process.
Asunto(s)
Toma de Decisiones , Conocimientos, Actitudes y Práctica en Salud , Parto Vaginal Después de Cesárea , Adulto , Cesárea/tendencias , Femenino , Humanos , Control Interno-Externo , Enfermería Obstétrica , Relaciones Médico-Paciente , Embarazo , Autoeficacia , Apoyo Social , Sudeste de Estados Unidos , Parto Vaginal Después de Cesárea/enfermeríaRESUMEN
The detection of the abuse of anabolic steroids in equine sport is complicated by the endogenous nature of some of the abused steroids, such as testosterone and nandrolone. These steroids are commonly administered as intramuscular injections of esterified forms of the steroid, which prolongs their effects and improves bioavailability over oral dosing. The successful detection of an intact anabolic steroid ester therefore provides unequivocal proof of an illegal administration, as esterified forms are not found endogenously. Detection of intact anabolic steroid esters is possible in plasma samples but not, to date, in the traditional doping control matrix of urine. The analysis of equine mane hair for the detection of anabolic steroid esters has the potential to greatly extend the time period over which detection of abuse can be monitored. Equine mane hair samples were incubated in 0.1M phosphate buffer (pH 9.5) before anabolic steroids (testosterone, nandrolone, boldenone, trenbolone and stanozolol), anabolic steroid esters (esters of testosterone, nandrolone, boldenone and trenbolone) and associated compounds (fluticasone propionate and esters of hydroxyprogesterone) were extracted by liquid-liquid extraction with a mix of hexane and ethyl acetate (7:3, v:v). Further sample clean up by solid phase extraction was followed by derivatisation with methoxylamine HCL and analysis by UHPLC-MS/MS. Initial method development was performed on a representative suite of four testosterone esters (propionate, phenylpropionate, isocaproate and decanoate) and the method was later extended to include a further 18 compounds. The applicability of the method was demonstrated by the analysis of mane hair samples collected following the intramuscular administration of 500 mg of Durateston(®) (mixed testosterone esters) to a Thoroughbred mare (560 kg). The method was subsequently used to successfully detect boldenone undecylenate and stanozolol in hair samples collected following suspicious screening findings from post-race urine samples. The use of segmental analysis to potentially provide additional information on the timing of administration was also investigated.